This study is testing valbenazine, an oral capsule, to see if it can help adults with trichotillomania (hair-pulling disorder). Participants will receive either valbenazine or a placebo (an inactive capsule that looks the same) for 12 weeks. After this, all participants will receive valbenazine for another 12 weeks. The study aims to find the best dose of valbenazine (either 40mg or 80mg) and measure how much hair-pulling symptoms improve using a special scale. You can join if you are an adult between 18 and 65 years old, in good health, and on a stable psychiatric medication regimen. The current recruitment status is unclear.

Study design

This is a double-blind, placebo-controlled study where participants are randomly assigned to receive either valbenazine or placebo. Approximately 20 participants will be enrolled.

What's involved

You would take an oral capsule daily for 24 weeks, with the first 12 weeks being either valbenazine or placebo, and the next 12 weeks being valbenazine. Your dose may be adjusted during the first few weeks.

Compensation

Not stated in the trial record.

Follow-up

You will have follow-up assessments at the end of week 26, which is two weeks after your last dose of valbenazine.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.